Niagen Bioscience Inc. held its Annual Meeting of Stockholders on June 24, 2025. During the meeting, several proposals were presented and approved. The amendment to the 2017 Equity Incentive Plan, which increases the number of shares available for issuance by 4.75 million shares of common stock, was approved. The Employee Stock Purchase Plan, allowing officers and employees to purchase shares at a discount, was also approved. Additionally, the election of directors was confirmed, with all nominated directors elected to serve.